Rhabdomyosarcoma of the prostate in children: A Case Report

Kanta Ka 1, *, Lissoune Cissé 3, Oumar Gaye 4, Babacar Sine 2, 5, Mohamed Jalloh 4, 5, Ndeye Aby Ndoye 3, 5, Gabriel Ngom 3, 5, Alain Khassimou Ndoye 2, 5 and Papa Macoumba Gaye 1, 5

1 Radiotherapy Department of the National Universitary Hospital Center Dalal Jamm, Guédiawaye, Senegal.
2 Urology Department of the Hospital Universitary Center Aristide Le Dantec, Dakar, Senegal.
3 Department of Pediatric Surgery, Albert Royer Children's Hospital, Dakar, Senegal.
4 Urology Department, General Hospital Idrissa Pouye, Grand Yoff, Senegal.
5 Cheikh Anta Diop University of Dakar, Senegal.
 
Case Study
World Journal of Advanced Research and Reviews, 2021, 11(03), 312–315
Article DOI: 10.30574/wjarr.2021.11.3.0475
 
Publication history: 
Received on 16 August 2021; revised on 25 September 2021; accepted on 27 September 2021
 
Abstract: 
Context: The therapeutic transition from mutilating surgery to external radiotherapy followed by brachytherapy is increasingly effective in the treatment of rhabdomyosarcoma.
Case presentation: 13-year-old child with no medical and surgical history, received for complete urine retention. Imaging examinations revealed a prostatic mass of 6 cm. The anatomopathological examination reveals an embryonic rhabdomyosarcoma. There was no recurrence after 3 years of follow-up after a multimodal treatment combining chemotherapy, external radiotherapy and high dose interstitial brachytherapy.
Conclusion: Vesicoprostatic rhabdomyosarcomas in children are rare. The therapeutic strategy has evolved over the years owing to the technological advances in external radiotherapy and brachytherapy.
 
Keywords: 
Rhabdomyosarcoma; Children; Brachytherapy; Prostate; Cancer
 
Full text article in PDF: 
Share this